ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma

BACKGROUND: The targeted therapy for lung cancer relies on prognostic genes and requires further research. No research has been conducted to determine the effect of endothelin-converting enzyme 2 (ECE2) in lung cancer. METHODS: We analyzed the expression of ECE2 in lung adenocarcinoma (LUAD) and nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yao-Hua, Zeng, Jing, Liu, Xu-Sheng, Gao, Yan, Kui, Xue-Yan, Liu, Xiao-Yu, Zhang, Yu, Pei, Zhi-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588963/
https://www.ncbi.nlm.nih.gov/pubmed/36299451
http://dx.doi.org/10.3389/fendo.2022.1013238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588963/
https://www.ncbi.nlm.nih.gov/pubmed/36299451
http://dx.doi.org/10.3389/fendo.2022.1013238

Ejemplares similares